Evidence map›Paper›PMID 23909633›Full record

ReviewCurrent cardiology reviews2013

The autocrine/paracrine loop after myocardial stretch: mineralocorticoid receptor activation.

Irene L Ennis, Ernesto A Aiello, Horacio E Cingolani, Nestor G Perez

Open access · bronzeAbstract readReview
In one paragraph

Review in Current cardiology reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. The Remaining Conundrum of the Role of the NaReviews in cardiovascular medicine · 2022
    Review
  4. Article
  5. Article
  6. Cardiac Mineralocorticoid Receptor and the NaFrontiers in cardiovascular medicine · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. The cardiac muscle duplex as a method to study myocardial heterogeneity.Progress in biophysics and molecular biology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Irene L EnnisCentro de Investigaciones Cardiovasculares, Facultad de Ciencias Medicas, Universidad Nacional de La Plata, Argentina.
Ernesto A Aiello
Horacio E Cingolani
Nestor G Perez
Centro de Investigaciones Cardiovasculares · ARConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The stretch of cardiac muscle increases developed force in two phases. The first phase, which occurs rapidly, constitutes the well-known Frank-Starling mechanism and it is generally attributed to enhanced myofilament responsiveness to Ca(2+). The second phase or slow force response (SFR) occurs gradually and is due to an increase in the calcium transient amplitude as a result of a stretch-triggered autocrine/paracrine mechanism. We previously showed that Ca(2+) entry through reverse Na(+)/Ca(2+) exchange underlies the SFR, as the final step of an autocrine/paracrine cascade involving release of angiotensin II/endothelin, and a Na(+)/H(+) exchanger (NHE-1) activation-mediated rise in Na+. In the present review we mainly focus on our three latest contributions to the understanding of this signalling pathway triggered by myocardial stretch: 1) The finding that an increased production of reactive oxygen species (ROS) from mitochondrial origin is critical in the activation of the NHE-1 and therefore in the genesis of the SFR; 2) the demonstration of a key role played by the transactivation of the epidermal growth factor receptor; and 3) the involvement of mineralocorticoid receptors (MR) activation in the stretch-triggered cascade leading to the SFR. Among these novel contributions, the critical role played by the MR is perhaps the most important one. This finding may conceivably provide a mechanistic explanation to the recently discovered strikingly beneficial effects of MR antagonism in humans with cardiac hypertrophy and failure.

Indexed as

Angiotensin IIAutocrine CommunicationCalciumCardiomegalyCardiovascular DiseasesHeart FailureHumansMyocardial ContractionMyocardiumParacrine CommunicationReactive Oxygen SpeciesReceptors, MineralocorticoidSodium-Calcium ExchangerSodium-Hydrogen ExchangersThyroid HormonesAngiotensin IICalciumgrowth factor-activatable Na-H exchanger NHE-1Reactive Oxygen SpeciesReceptors, MineralocorticoidSodium-Calcium ExchangerSodium-Hydrogen ExchangersThyroid Hormones

Identifiers

PMID23909633
PMCPMC3780348
OpenAlexW2102851659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.